<DOC>
	<DOCNO>NCT02199418</DOCNO>
	<brief_summary>The investigator hypotheses paclitaxel combine cisplatin weekly-based regimen neoadjuvant chemotherapy effective tolerable locally advanced breast cancer .</brief_summary>
	<brief_title>Addition Cisplatin Neoadjuvant Therapy T Locally Advanced Breast Cancer</brief_title>
	<detailed_description>In trial , patient weekly paclitaxel cisplatin neoadjuvant chemotherapy 4 cycle . Patients Her2 positive tumor also receive trastuzumab .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Inflammatory Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Ductal , Breast</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Women age ≥18years ≤70 year 2 . At least measurable disease accord Response Evaluation Criteria Solid Tumors ( RECIST ) . Histologically confirm invasive breast cancer , tumor size ≥2 cm , T24 N02M0 3 . ER/PR/HER2 Ki67 status detect core biopsy . ER/PR positive define &gt; 1 % stained cell HER2positive define immunohistochemistry ( IHC ) 3+ FISH ratio ≥ 2.0 4 . No prior systemic locoregional treatment breast cancer 5 . ECOG 02 6 . Adequate bone marrow function : WBC≥4.0×109/L , Absolute neutrophil count（ANC）≥1.5×109/L , Platelets（PLT）≥100×109/L , Hemoglobin（Hb）≥90g/L ; aspartate aminotransferase ( AST ) , Alanine aminotransferase ( ALT ) ≤1.5 upper normal limit （UNL） , creatinine≤1.5 UNL , bilirubin≤1.5UNL 7 . No obvious main organ dysfunction 1 . Unwilling unable use acceptable method contraception 8 week ( include 8 week ) final dose test drug 2 . Patient pregnant breast feed 3 . Inflammatory breast cancer metastatic breast cancer 4 . Any evidence sense motor nerve disorder 5 . Patients medical condition taht indicate intolerant neoadjuvant therapy , include uncontrolled cardiovascular disease , severe infection 6 . Any concurrent malignancy breast cancer 7 . Know severe hypersensitivity drug study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>